Are you currently or have you previously used a Proventil Albuterol HFA Inhaler with Dose Indicator or a Generic Proventil device?

If so, you may be eligible to participate in evaluating a new inhaler.

Are you currently or have you previously used a Proventil Albuterol HFA Inhaler with Dose Indicator or a Generic Proventil device? If so, you may be eligible to participate in evaluating a new inhaler.

What is a clinical trial? Is participating in a clinical trial right for you? Learn more

Inhaler Product Evaluation Study in Nashville TN
PWT009252019 | Phase 1 | Observational

What you may receive

Compensation of up to $200

Extended travel distances may be compensated

Cipla Ltd
Sponsored by
Cipla Ltd

Are you currently or have you previously used a Proventil Albuterol HFA Inhaler with Dose Indicator or a Generic Proventil device?

If so, you may be eligible to participate in evaluating a new inhaler.

Are you currently or have you previously used a Proventil Albuterol HFA Inhaler with Dose Indicator or a Generic Proventil device? If so, you may be eligible to participate in evaluating a new inhaler.

Completed

Male & Female

4 Years +

This study has recruited 300 Participants

Time commitment required is 45 minutes. This evaluation is seeking adult and pediatric patients who are currently using or have used an inhaler with a dose indicator, as well as individuals responsible for helping others use such inhalers. As part of this study, patients will be asked to simulate (pretend) using two inhalers – one that is on the market, and a new product . During the evaluation, patients will not be asked to inhale any medicine or change anything about their current medication regimen. Rather, this study evaluates the patient’s experience with the new product.

Why should I participate?

Participation in this study will help the research team evaluate whether a new device is easy or difficult to use. If you qualify to participate, you are eligible for $200 in compensation. Additional compensation may be provided for those traveling extended distances.

Frequently Asked Questions
Will I get paid?

If eligible and if you complete the in-person evaluation, yes, you are eligible for up to $200 in compensation. If travelling for extended distances, you may be eligible for additional compensation as well.

How long is the study?

If you are eligible and you want to participate, you would come in for one 45-minute product evaluation session in-person with a researcher (this is not a focus group).

Will I be taking any medication?

No. This study will simply be evaluating a user’s experience with the inhaler. No medication will be inhaled at any point.